{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T12:32:29Z","timestamp":1773145949757,"version":"3.50.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2002,7,1]],"date-time":"2002-07-01T00:00:00Z","timestamp":1025481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,7,1]],"date-time":"2002-07-01T00:00:00Z","timestamp":1025481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2002,7]]},"DOI":"10.1007\/s11864-002-0029-9","type":"journal-article","created":{"date-parts":[[2007,6,28]],"date-time":"2007-06-28T08:59:39Z","timestamp":1183021179000},"page":"291-305","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Burkitt\u2019s and Burkitt-like Lymphoma"],"prefix":"10.1007","volume":"3","author":[{"given":"Andrew M.","family":"Evens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leo I.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"29_CR1","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1200\/JCO.2001.19.20.4014","volume":"19","author":"EJ Lee","year":"2001","unstructured":"Lee EJ, Petroni GR, Schiffer CA, et al.: Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251. J Clin Oncol\n                           2001, 19:4014\u20134022.","journal-title":"J Clin Oncol"},{"key":"29_CR2","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1200\/JCO.1996.14.3.925","volume":"14","author":"I Magrath","year":"1996","unstructured":"Magrath I, Adde M, Shad A, et al.: Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol\n                           1996, 14:925\u2013934.","journal-title":"J Clin Oncol"},{"key":"29_CR3","first-page":"33","volume":"25","author":"M Adde","year":"1998","unstructured":"Adde M, Shad A, Venzon D, et al.: Additional chemotherapy agents improve treatment outcome for children and adults with advanced B-cell lymphomas. Semin Oncol\n                           1998, 25:33\u201339.","journal-title":"Semin Oncol"},{"key":"29_CR4","doi-asserted-by":"publisher","first-page":"3370","DOI":"10.1182\/blood.V97.11.3370","volume":"97","author":"C Patte","year":"2001","unstructured":"Patte C, Auperin A, Michon J, et al.: The Societe Francaise d\u2019Oncologie Pediatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood\n                           2001, 97:3370\u20133379.","journal-title":"Blood"},{"key":"29_CR5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1200\/JCO.2000.18.3.547","volume":"18","author":"HM Kantarjian","year":"2000","unstructured":"Kantarjian HM, O\u2019Brien S, Smith TL, et al.: Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. J Clin Oncol\n                           2000, 18:547\u2013561.","journal-title":"J Clin Oncol"},{"key":"29_CR6","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1182\/blood.V85.8.2025.bloodjournal8582025","volume":"85","author":"RA Larson","year":"1995","unstructured":"Larson RA, Dodge RK, Burns CP, et al.: A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811. Blood\n                           1995, 85:2025\u20132037.","journal-title":"Blood"},{"key":"29_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0889-8588(05)70199-4","volume":"15","author":"P Fenaux","year":"2001","unstructured":"Fenaux P, Bourhis JH, Ribrag V: Burkitt\u2019s acute lymphocytic leukemia (L3ALL) in adults. Hematol Oncol Clin North Am\n                           2001, 15:37\u201350.","journal-title":"Hematol Oncol Clin North Am"},{"key":"29_CR8","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","volume":"84","author":"NL Harris","year":"1994","unstructured":"Harris NL, Jaffe ES, Stein H, et al.: A revised European- American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood\n                           1994, 84:1361\u20131392.","journal-title":"Blood"},{"key":"29_CR9","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","volume":"17","author":"NL Harris","year":"1999","unstructured":"Harris NL, Jaffe ES, Diebold J, et al.: World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting\u2014Airlie House, Virginia, November 1997. J Clin Oncol\n                           1999, 17:3835\u20133849.","journal-title":"J Clin Oncol"},{"key":"29_CR10","doi-asserted-by":"publisher","first-page":"3713","DOI":"10.1182\/blood.V97.12.3713","volume":"97","author":"RM Braziel","year":"2001","unstructured":"Braziel RM, Arber DA, Slovak ML, et al.: The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical features. Blood\n                           2001, 97:3713\u20133720.","journal-title":"Blood"},{"key":"29_CR11","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1182\/blood.V93.2.758","volume":"93","author":"DH Wright","year":"1999","unstructured":"Wright DH: What is Burkitt\u2019s lymphoma and when is it endemic? Blood\n                           1999, 93:758.","journal-title":"Blood"},{"key":"29_CR12","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1200\/JCO.2000.18.21.3707","volume":"18","author":"JL Hecht","year":"2000","unstructured":"Hecht JL, Aster JC: Molecular biology of Burkitt\u2019s lymphoma. J Clin Oncol\n                           2000, 18:3707\u20133721.","journal-title":"J Clin Oncol"},{"key":"29_CR13","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1002\/1097-0142(197212)30:6<1534::AID-CNCR2820300619>3.0.CO;2-6","volume":"30","author":"JL Ziegler","year":"1972","unstructured":"Ziegler JL: Chemotherapy of Burkitt\u2019s lymphoma. Cancer 1972, 30:1534\u20131540.","journal-title":"Cancer"},{"key":"29_CR14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1056\/NEJM197707142970202","volume":"297","author":"JL Ziegler","year":"1977","unstructured":"Ziegler JL: Treatment results of 54 American patients with Burkitt\u2019s lymphoma are similar to the African experience. N Engl J Med\n                           1977, 297:75\u201380.","journal-title":"N Engl J Med"},{"key":"29_CR15","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1200\/JCO.1996.14.4.1252","volume":"14","author":"WP Bowman","year":"1996","unstructured":"Bowman WP, Shuster JJ, Cook B, et al.: Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a pediatric oncology group study. J Clin Oncol\n                           1996, 14:1252\u20131261.","journal-title":"J Clin Oncol"},{"key":"29_CR16","first-page":"442","volume":"81","author":"T Lerede","year":"1996","unstructured":"Lerede T, Bassan R, Rossi A, et al.: Therapeutic impact of adult-type acute lymphoblastic leukemia regimens in B-cell\/L3 acute leukemia and advanced-stage Burkitt\u2019s lymphoma. Haematologica\n                           1996, 81:442\u2013449.","journal-title":"Haematologica"},{"key":"29_CR17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1040-8428(86)80013-0","volume":"4","author":"BD Clarkson","year":"1986","unstructured":"Clarkson BD, Gee T, Arlin ZA, et al.: Current status of treatment of acute leukemia in adults: an overview of the Memorial experience and review of literature. Crit Rev Oncol Hematol\n                           1986, 4:221\u2013248.","journal-title":"Crit Rev Oncol Hematol"},{"key":"29_CR18","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1182\/blood.V87.2.495.bloodjournal872495","volume":"87","author":"D Hoelzer","year":"1996","unstructured":"Hoelzer D, Ludwig WD, Thiel E, et al.: Improved outcome in adult B-cell acute lymphoblastic leukemia. Blood\n                           1996, 87:495\u2013508.","journal-title":"Blood"},{"key":"29_CR19","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0950-3536(05)80206-9","volume":"7","author":"C Patte","year":"1994","unstructured":"Patte C, Michon J, Frappaz D, et al.: Therapy of Burkitt and other B-cell acute lymphoblastic leukaemia and lymphoma: experience with the LMB protocols of the SFOP (French Paediatric Oncology Society) in children and adults. Baillieres Clin Haematol\n                           1994, 7:339\u2013348.","journal-title":"Baillieres Clin Haematol"},{"key":"29_CR20","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/bjc.1998.379","volume":"77","author":"A Atra","year":"1998","unstructured":"Atra A, Gerrard M, Hobson R, et al.: Improved cure rate in children with B-cell acute lymphoblastic leukaemia (B-ALL) and stage IV B-cell non-Hodgkin\u2019s lymphoma (B-NHL): results of the UKCCSG 9003 protocol. Br J Cancer\n                           1998, 77:2281\u20132285.","journal-title":"Br J Cancer"},{"key":"29_CR21","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/1097-0142(19910715)68:2<233::AID-CNCR2820680203>3.0.CO;2-Q","volume":"68","author":"ML McMaster","year":"1991","unstructured":"McMaster ML, Greer JP, Wolff SN, et al.: Results of treatment with high intensity, brief duration chemotherapy in poor prognosis non-Hodgkin\u2019s lymphoma. Cancer\n                           1991, 68:233\u2013241.","journal-title":"Cancer"},{"key":"29_CR22","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/BF01703945","volume":"65","author":"HW Pees","year":"1992","unstructured":"Pees HW, Radtke H, Schwamborn J, Graf N: The BFMprotocol for HIV-negative Burkitt\u2019s lymphomas and L3 ALL in adult patients: a high chance for cure. Ann Hematol\n                           1992, 65:201\u2013205.","journal-title":"Ann Hematol"},{"key":"29_CR23","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/0002-9343(91)80013-C","volume":"90","author":"DJ Straus","year":"1991","unstructured":"Straus DJ, Wong GY, Liu J, et al.: Small non-cleaved-cell lymphoma (undifferentiated lymphoma, Burkitt\u2019s type) in American adults: results with treatment designed for acute lymphoblastic leukemia. Am J Med\n                           1991, 90:328\u2013337.","journal-title":"Am J Med"},{"key":"29_CR24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1023\/A:1008214203225","volume":"8","author":"G Todeschini","year":"1997","unstructured":"Todeschini G, Tecchio C, Degani D, et al.: Eighty-one percent event-free survival in advanced Burkitt\u2019s lymphoma\/leukemia: no differences in outcome between pediatric and adult patients treated with the same intensive pediatric protocol. Ann Oncol\n                           1997, 8:77\u201381.","journal-title":"Ann Oncol"},{"key":"29_CR25","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1200\/JCO.1996.14.3.935","volume":"14","author":"M Weintraub","year":"1996","unstructured":"Weintraub M, Adde MA, Venzon DJ, et al.: Severe atypical neuropathy associated with administration of hematopoietic colony-stimulating factors and vincristine. J Clin Oncol\n                           1996, 14:935\u2013940.","journal-title":"J Clin Oncol"},{"key":"29_CR26","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1046\/j.1365-2141.2001.02647.x","volume":"112","author":"A Atra","year":"2001","unstructured":"Atra A, Gerrard M, Hobson R, et al.: Outcome of relapsed or refractory childhood B-cell acute lymphoblastic leukaemia and B-cell non-Hodgkin\u2019s lymphoma treated with the UKCCSG 9003\/9002 protocols. Br J Haematol\n                           2001, 112:965\u2013968.","journal-title":"Br J Haematol"},{"key":"29_CR27","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1182\/blood.V81.8.2003.2003","volume":"81","author":"T Philip","year":"1993","unstructured":"Philip T, Hartmann O, Pinkerton R, et al.: Curability of relapsed childhood B-cell non-Hodgkin\u2019s lymphoma after intensive first line therapy: a report from the Societe Francaise d\u2019Oncologie Pediatrique. Blood\n                           1993, 81:2003\u20132006.","journal-title":"Blood"},{"key":"29_CR28","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1182\/blood.V85.3.664.bloodjournal853664","volume":"85","author":"C Soussain","year":"1995","unstructured":"Soussain C, Patte C, Ostronoff M, et al.: Small noncleaved cell lymphoma and leukemia in adults: a retrospective study of 65 adults treated with the LMB pediatric protocols. Blood\n                           1995, 85:664\u2013674.","journal-title":"Blood"},{"key":"29_CR29","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1200\/JCO.1996.14.9.2465","volume":"14","author":"JW Sweetenham","year":"1996","unstructured":"Sweetenham JW, Pearce R, Taghipour G, et al.: Adult Burkitt\u2019s and Burkitt-like non-Hodgkin\u2019s lymphoma\u2014outcome for patients treated with high-dose therapy and autologous stem-cell transplantation in first remission or at relapse: results from the European Group for Blood and Marrow Transplantation. J Clin Oncol\n                           1996, 14:2465\u20132472.","journal-title":"J Clin Oncol"},{"key":"29_CR30","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1182\/blood.V90.10.3844","volume":"90","author":"A Nademanee","year":"1997","unstructured":"Nademanee A, Molina A, O\u2019Donnell MR, et al.: Results of high-dose therapy and autologous bone marrow\/ stem cell transplantation during remission in poor-risk intermediate- and high-grade lymphoma: international index high and high-intermediate risk group. Blood\n                           1997, 90:3844\u20133852.","journal-title":"Blood"},{"key":"29_CR31","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3816\/CLM.2000.n.004","volume":"1","author":"A Nademanee","year":"2000","unstructured":"Nademanee A, Molina A, Dagis A, et al.: Autologous stem-cell transplantation for poor-risk and relapsed intermediate- and high-grade non-Hodgkin\u2019s lymphoma. Clin Lymphoma\n                           2000, 1:46\u201354.","journal-title":"Clin Lymphoma"},{"key":"29_CR32","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1182\/blood.V87.6.2195.bloodjournal8762195","volume":"87","author":"S Slavin","year":"1996","unstructured":"Slavin S, Naparstek E, Nagler A, et al.: Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation. Blood\n                           1996, 87:2195\u20132204.","journal-title":"Blood"},{"key":"29_CR33","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1200\/JCO.1990.8.5.809","volume":"8","author":"X Troussard","year":"1990","unstructured":"Troussard X, Leblond V, Kuentz M, et al.: Allogeneic bone marrow transplantation in adults with Burkitt\u2019s lymphoma or acute lymphoblastic leukemia in first complete remission. J Clin Oncol\n                           1990, 8:809\u2013812.","journal-title":"J Clin Oncol"},{"key":"29_CR34","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/sj.bmt.1702730","volume":"26","author":"A Ungkanont","year":"2000","unstructured":"Ungkanont A, Mongkonsritrakoon W, Jootar S, Srichaikul T: Allogeneic stem cell transplantation in a patient with refractory Burkitt\u2019s lymphoma using non-myeloablative conditioning regimen. Bone Marrow Transplant\n                           2000, 26:1351\u20131354.","journal-title":"Bone Marrow Transplant"},{"key":"29_CR35","first-page":"353","volume":"15","author":"E Bureo","year":"1995","unstructured":"Bureo E, Ortega JJ, Munoz A, et al.: Bone marrow transplantation in 46 pediatric patients with non- Hodgkin\u2019s lymphoma. Spanish Working Party for Bone Marrow Transplantation in Children. Bone Marrow Transplant\n                           1995, 15:353\u2013359.","journal-title":"Bone Marrow Transplant"},{"key":"29_CR36","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/(SICI)1097-0142(19980215)82:4<766::AID-CNCR21>3.0.CO;2-V","volume":"82","author":"M Spina","year":"1998","unstructured":"Spina M, Tirelli U, Zagonel V, et al.: Burkitt\u2019s lymphoma in adults with and without human immunodeficiency virus infection: a single-institution clinicopathologic study of 75 patients. Cancer\n                           1998, 82:766\u2013774.","journal-title":"Cancer"},{"key":"29_CR37","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.1182\/blood.V98.12.3406","volume":"98","author":"O Kirk","year":"2001","unstructured":"Kirk O, Pedersen C, Cozzi-Lepri A, et al.: Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy. Blood\n                           2001, 98:3406\u20133412.","journal-title":"Blood"},{"key":"29_CR38","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1200\/JCO.2001.19.8.2171","volume":"19","author":"L Ratner","year":"2001","unstructured":"Ratner L, Lee J, Tang S, et al.: Chemotherapy for human immunodeficiency virus-associated non-Hodgkin\u2019s lymphoma in combination with highly active antiretroviral therapy. J Clin Oncol\n                           2001, 19:2171\u20132178.","journal-title":"J Clin Oncol"},{"key":"29_CR39","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1200\/JCO.1998.16.11.3601","volume":"16","author":"DJ Straus","year":"1998","unstructured":"Straus DJ, Huang J, Testa MA, Levine AM, Kaplan LD: Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin\u2019s lymphoma: analysis of AIDS Clinical Trials Group protocol 142\u2014low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colonystimulating factor. National Institute of Allergy and Infectious Diseases. J Clin Oncol\n                           1998, 16:3601\u20133606.","journal-title":"J Clin Oncol"},{"key":"29_CR40","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1200\/JCO.1998.16.12.3788","volume":"16","author":"F Davi","year":"1998","unstructured":"Davi F, Delecluse HJ, Guiet P, et al.: Burkitt-like lymphomas in AIDS patients: characterization within a series of 103 human immunodeficiency virus-associated non- Hodgkin\u2019s lymphomas. Burkitt\u2019s Lymphoma Study Group. J Clin Oncol\n                           1998, 16:3788\u20133795.","journal-title":"J Clin Oncol"},{"key":"29_CR41","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-3-642-56352-2_18","volume":"159","author":"U Tirelli","year":"2002","unstructured":"Tirelli U, Spina M, Jaeger U, et al.: Infusional CDE with rituximab for the treatment of human immunodeficiency virus-associated non-Hodgkin\u2019s lymphoma: preliminary results of a phase I\/II study. Recent Results Cancer Res\n                           2002, 159:149\u2013153.","journal-title":"Recent Results Cancer Res"},{"key":"29_CR42","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/S0959-8049(01)00106-X","volume":"37","author":"U Tirelli","year":"2001","unstructured":"Tirelli U, Bernardi D: Impact of HAART on the clinical management of AIDS-related cancers. Eur J Cancer\n                           2001, 37:1320\u20131324.","journal-title":"Eur J Cancer"},{"key":"29_CR43","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1002\/(SICI)1097-0142(20000401)88:7<1696::AID-CNCR25>3.0.CO;2-L","volume":"88","author":"F Thiessard","year":"2000","unstructured":"Thiessard F, Morlat P, Marimoutou C, et al.: Prognostic factors after non-Hodgkin lymphoma in patients infected with the human immunodeficiency virus: Aquitaine Cohort, France, 1986-1997. Groupe d\u2019Epidemiologie Clinique du SIDA en Aquitaine (GECSA). Cancer\n                           2000, 88:1696\u20131702.","journal-title":"Cancer"},{"key":"29_CR44","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1182\/blood.V96.8.2730","volume":"96","author":"GV Matthews","year":"2000","unstructured":"Matthews GV, Bower M, Mandalia S, et al.: Changes in acquired immunodeficiency syndrome-related lymphoma since the introduction of highly active antiretroviral therapy. Blood\n                           2000, 96:2730\u20132734.","journal-title":"Blood"},{"key":"29_CR45","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.1182\/blood.V98.13.3857","volume":"98","author":"A Krishnan","year":"2001","unstructured":"Krishnan A, Molina A, Zaia J, et al.: Autologous stem cell transplantation for HIV-associated lymphoma. Blood\n                           2001, 98:3857\u20133859.","journal-title":"Blood"},{"key":"29_CR46","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1046\/j.1365-2141.1999.01422.x","volume":"105","author":"P Campbell","year":"1999","unstructured":"Campbell P, Iland H, Gibson J, Joshua D: Syngeneic stem cell transplantation for HIV-related lymphoma. Br J Haematol\n                           1999, 105:795\u2013798.","journal-title":"Br J Haematol"},{"key":"29_CR47","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1002\/1097-0142(20000801)89:3<680::AID-CNCR25>3.0.CO;2-W","volume":"89","author":"A Molina","year":"2000","unstructured":"Molina A, Krishnan AY, Nademanee A, et al.: High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non- Hodgkin lymphoma in the era of highly active antiretroviral therapy. Cancer\n                           2000, 89:680\u2013689.","journal-title":"Cancer"},{"key":"29_CR48","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/S0140-6736(00)02041-9","volume":"355","author":"J Gabarre","year":"2000","unstructured":"Gabarre J, Azar N, Autran B, et al.: High-dose therapy and autologous haematopoietic stem-cell transplantation for HIV-1-associated lymphoma. Lancet\n                           2000, 355:1071\u20131072.","journal-title":"Lancet"},{"key":"29_CR49","first-page":"629","volume":"15","author":"AM Levine","year":"2001","unstructured":"Levine AM, Seneviratne L, Tulpule A: Incidence and management of AIDS-related lymphoma. Oncology (Huntingt)\n                           2001, 15:629\u2013639.","journal-title":"Oncology (Huntingt)"},{"key":"29_CR50","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1200\/JCO.1996.14.8.2217","volume":"14","author":"E Vaccher","year":"1996","unstructured":"Vaccher E, Tirelli U, Spina M, et al.: Age and serum lactate dehydrogenase level are independent prognostic factors in human immunodeficiency virus-related non-Hodgkin\u2019s lymphomas: a single-institute study of 96 patients. J Clin Oncol\n                           1996, 14:2217\u20132223.","journal-title":"J Clin Oncol"},{"key":"29_CR51","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/BF00860751","volume":"9","author":"DP Jones","year":"1995","unstructured":"Jones DP, Mahmoud H, Chesney RW: Tumor lysis syndrome: pathogenesis and management. Pediatr Nephrol 1995, 9:206\u2013212.","journal-title":"Pediatr Nephrol"},{"key":"29_CR52","first-page":"322","volume":"27","author":"CD Flombaum","year":"2000","unstructured":"Flombaum CD: Metabolic emergencies in the cancer patient. Semin Oncol\n                           2000, 27:322\u2013334.","journal-title":"Semin Oncol"},{"key":"29_CR53","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/S0022-3476(68)80209-4","volume":"72","author":"P Holland","year":"1968","unstructured":"Holland P, Holland NH: Prevention and management of acute hyperuricemia in childhood leukemia. J Pediatr\n                           1968, 72:358\u2013366.","journal-title":"J Pediatr"},{"key":"29_CR54","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/S0749-2081(98)80009-0","volume":"14","author":"DK Hogan","year":"1998","unstructured":"Hogan DK, Rosenthal LD: Oncologic emergencies in the patient with lymphoma. Semin Oncol Nurs\n                           1998, 14:312\u2013320.","journal-title":"Semin Oncol Nurs"},{"key":"29_CR55","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1200\/JCO.2000.18.8.1758","volume":"18","author":"RV Smalley","year":"2000","unstructured":"Smalley RV, Guaspari A, Haase-Statz S, et al.: Allopurinol: intravenous use for prevention and treatment of hyperuricemia. J Clin Oncol\n                           2000, 18:1758\u20131763.","journal-title":"J Clin Oncol"},{"key":"29_CR56","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0037-1963(01)90039-3","volume":"38","author":"CH Pui","year":"2001","unstructured":"Pui CH: Urate oxidase in the prophylaxis or treatment of hyperuricemia: the United States experience. Semin Hematol\n                           2001, 38:13\u201321.","journal-title":"Semin Hematol"},{"key":"29_CR57","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1056\/NEJM199004263221701","volume":"322","author":"MP Link","year":"1990","unstructured":"Link MP, Donaldson SS, Berard CW, et al.: Results of treatment of childhood localized non-Hodgkin\u2019s lymphoma with combination chemotherapy with or without radiotherapy. N Engl J Med\n                           1990, 322:1169\u20131174.","journal-title":"N Engl J Med"},{"key":"29_CR58","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1056\/NEJM199710303371802","volume":"337","author":"MP Link","year":"1997","unstructured":"Link MP, Shuster JJ, Donaldson SS, et al.: Treatment of children and young adults with early-stage non-Hodgkin\u2019s lymphoma. N Engl J Med\n                           1997, 337:1259\u20131266.","journal-title":"N Engl J Med"},{"key":"29_CR59","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3109\/08880019709030912","volume":"14","author":"I Miron","year":"1997","unstructured":"Miron I, Frappaz D, Brunat-Mentigny M, et al.: Initial management of advanced Burkitt lymphoma in children: is there still a place for surgery? Pediatr Hematol Oncol\n                           1997, 14:555\u2013561.","journal-title":"Pediatr Hematol Oncol"},{"key":"29_CR60","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/0022-3468(92)90319-3","volume":"27","author":"RC Shamberger","year":"1992","unstructured":"Shamberger RC, Weinstein HJ: The role of surgery in abdominal Burkitt\u2019s lymphoma. J Pediatr Surg\n                           1992, 27:236\u2013240.","journal-title":"J Pediatr Surg"},{"key":"29_CR61","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1210\/jc.87.1.105","volume":"87","author":"C Thieblemont","year":"2002","unstructured":"Thieblemont C, Mayer A, Dumontet C, et al.: Primary thyroid lymphoma is a heterogeneous disease. J Clin Endocrinol Metab\n                           2002, 87:105\u2013111.","journal-title":"J Clin Endocrinol Metab"},{"key":"29_CR62","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/00000658-198207000-00017","volume":"196","author":"MM Kemeny","year":"1982","unstructured":"Kemeny MM, Magrath IT, Brennan MF: The role of surgery in the management of American Burkitt\u2019s lymphoma and its treatment. Ann Surg\n                           1982, 196:82\u201386.","journal-title":"Ann Surg"},{"key":"29_CR63","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/BF00301252","volume":"12","author":"G Dechambenoit","year":"1996","unstructured":"Dechambenoit G, Piquemal M, Giordano C, et al.: Spinal cord compression resulting from Burkitt\u2019s lymphoma in children. Childs Nerv Syst\n                           1996, 12:210\u2013214.","journal-title":"Childs Nerv Syst"},{"key":"29_CR64","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.1007\/s002800100312","volume":"48","author":"TE Witzig","year":"2001","unstructured":"Witzig TE: Radioimmunotherapy for patients with relapsed B-cell non-Hodgkin lymphoma. Cancer Chemother Pharmacol\n                           2001, 48:S91-S95.","journal-title":"Cancer Chemother Pharmacol"},{"key":"29_CR65","unstructured":"Thomas DA: Rituximab and hyper-CVAD for adult Burkitt\u2019s (BL) or Burkitt-like (BLL) leukemia or lymphoma.\n                           Blood 2001:a3342."},{"key":"29_CR66","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1200\/JCO.1999.17.5.1558","volume":"17","author":"N Macpherson","year":"1999","unstructured":"Macpherson N, Lesack D, Klasa R, et al.: Small noncleaved, non-Burkitt\u2019s (Burkit-like) lymphoma: cytogenetics predict outcome and reflect clinical presentation. J Clin Oncol\n                           1999, 17:1558\u20131567.","journal-title":"J Clin Oncol"},{"key":"29_CR67","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1038\/sj.onc.1203686","volume":"19","author":"M Bemark","year":"2000","unstructured":"Bemark M, Neuberger MS: The c-MYC allele that is translocated into the IgH locus undergoes constitutive hypermutation in a Burkitt\u2019s lymphoma line. Oncogene\n                           2000, 19:3404\u20133410.","journal-title":"Oncogene"},{"key":"29_CR68","doi-asserted-by":"publisher","first-page":"9819","DOI":"10.1074\/jbc.M111426200","volume":"277","author":"HM Hu","year":"2002","unstructured":"Hu HM, Arcinas M, Boxer LM: A Myc-associated zinc finger protein-related factor binding site is required for the deregulation of c-myc expression by the immunoglobulin heavy chain gene enhancers in Burkitt\u2019s lymphoma. J Biol Chem\n                           2002, 277:9819\u20139824.","journal-title":"J Biol Chem"},{"key":"29_CR69","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1128\/MCB.18.11.6281","volume":"18","author":"L Madisen","year":"1998","unstructured":"Madisen L, Krumm A, Hebbes TR, Groudine M: The immunoglobulin heavy chain locus control region increases histone acetylation along linked c-myc genes. Mol Cell Biol\n                           1998, 18:6281\u20136292.","journal-title":"Mol Cell Biol"},{"key":"29_CR70","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0960-9822(06)00183-7","volume":"7","author":"A Sommer","year":"1997","unstructured":"Sommer A, Hilfenhaus S, Menkel A, et al.: Cell growth inhibition by the Mad\/Max complex through recruitment of histone deacetylase activity. Curr Biol\n                           1997, 7:357\u2013365.","journal-title":"Curr Biol"},{"key":"29_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0378-1119(01)00697-7","volume":"277","author":"B Luscher","year":"2001","unstructured":"Luscher B: Function and regulation of the transcription factors of the Myc\/Max\/Mad network. Gene\n                           2001, 277:1\u201314.","journal-title":"Gene"},{"key":"29_CR72","doi-asserted-by":"publisher","first-page":"4650","DOI":"10.1038\/sj.onc.1204606","volume":"20","author":"X Yin","year":"2001","unstructured":"Yin X, Landay MF, Han W, et al.: Dynamic in vivo interactions among Myc network members. Oncogene\n                           2001, 20:4650\u20134664.","journal-title":"Oncogene"},{"key":"29_CR73","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/35000501","volume":"403","author":"AA Alizadeh","year":"2000","unstructured":"Alizadeh AA, Eisen MB, Davis RE, et al.: Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature\n                           2000, 403:503\u2013511.","journal-title":"Nature"},{"key":"29_CR74","doi-asserted-by":"publisher","first-page":"B38","DOI":"10.1007\/s002770000222","volume":"80","author":"WC Chan","year":"2001","unstructured":"Chan WC, Huang JZ: Gene expression analysis in aggressive NHL. Ann Hematol\n                           2001, 80:B38-B41.","journal-title":"Ann Hematol"},{"key":"29_CR75","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nm0102-68","volume":"8","author":"MA Shipp","year":"2002","unstructured":"Shipp MA, Ross KN, Tamayo P, et al.: Diffuse large B-cell lymphoma outcome prediction by geneexpression profiling and supervised machine learning. Nat Med\n                           2002, 8:68\u201374.","journal-title":"Nat Med"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-002-0029-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11864-002-0029-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-002-0029-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-002-0029-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T10:33:30Z","timestamp":1659090810000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11864-002-0029-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7]]},"references-count":75,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,7]]}},"alternative-id":["29"],"URL":"https:\/\/doi.org\/10.1007\/s11864-002-0029-9","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,7]]},"assertion":[{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}